|
C15ORF40 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67781000000033E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.09509999999913E-05 |
| Normal-vs-Stage2 |
2.433600E-04 |
| Normal-vs-Stage3 |
7.71480000000269E-05 |
| Normal-vs-Stage4 |
9.504400E-03 |
| Stage1-vs-Stage2 |
5.422000E-01 |
| Stage1-vs-Stage3 |
2.494400E-01 |
| Stage1-vs-Stage4 |
9.220000E-01 |
| Stage2-vs-Stage3 |
7.445600E-01 |
| Stage2-vs-Stage4 |
6.213600E-01 |
| Stage3-vs-Stage4 |
4.758800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.27690000004421E-06 |
| Normal-vs-AfricanAmerican |
1.637390E-03 |
| Normal-vs-Asian |
4.258800E-01 |
| Caucasian-vs-AfricanAmerican |
2.961000E-01 |
| Caucasian-vs-Asian |
7.705800E-01 |
| AfricanAmerican-vs-Asian |
9.290200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.48749999999243E-05 |
| Normal-vs-Female |
3.82880000000529E-05 |
| Male-vs-Female |
6.391600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.569100E-04 |
| Normal-vs-Extreme_Weight |
1.566450E-04 |
| Normal-vs-Obese |
5.7238000000015E-05 |
| Normal-vs-Extreme_Obese |
2.807700E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.417600E-01 |
| Normal_Weight-vs-Obese |
6.216200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.742400E-01 |
| Extreme_Weight-vs-Obese |
6.222800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.361800E-01 |
| Obese-vs-Extreme_Obese |
5.580800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.637800E-04 |
| Normal-vs-Age(41-60Yrs) |
4.394700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.15660000002504E-06 |
| Normal-vs-Age(81-100Yrs) |
8.958100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.626400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.542200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.882800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.991850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.487800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.452800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.475600E-03 |
| Normal-VS-Type2 PRCC |
9.01940000019863E-07 |
| Normal-VS-KIRP CIMP |
1.58579999998132E-06 |
| Normal-VS-Unclassified PRCC |
1.05819999995926E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.162400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.202500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.739300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.147700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.701000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.254000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.35429999998027E-06 |
| Normal-vs-N1 |
3.61049999997309E-06 |
| Normal-vs-N2 |
2.231100E-04 |
| N0-vs-N1 |
5.289800E-01 |
| N0-vs-N2 |
1.586790E-01 |
| N1-vs-N2 |
2.473400E-01 |
|
|
